Leys AM - Search Results

1

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.

Boyer DS, Goldbaum M, Leys AM, Starita C; V.I.S.I.O.N. Study Group. Boyer DS, et al. Among authors: leys am. Br J Ophthalmol. 2014 Nov;98(11):1543-6. doi: 10.1136/bjophthalmol-2013-304075. Epub 2014 Jul 4. Br J Ophthalmol. 2014. PMID: 24997182 Clinical Trial.

2

Early diagnosis and successful treatment of paraneoplastic melanocytic proliferation.

Jansen JC, Van Calster J, Pulido JS, Miles SL, Vile RG, Van Bergen T, Cassiman C, Spielberg LH, Leys AM. Jansen JC, et al. Among authors: leys am. Br J Ophthalmol. 2015 Jul;99(7):943-8. doi: 10.1136/bjophthalmol-2014-305893. Epub 2015 Apr 23. Br J Ophthalmol. 2015. PMID: 25908835 Free PMC article.

3

Intravitreal bevacizumab for myopic choroidal neovascularization: short-term and 1-year results.

Spielberg L, Leys A. Spielberg L, et al. Bull Soc Belge Ophtalmol. 2009;(312):17-27. Bull Soc Belge Ophtalmol. 2009. PMID: 19927486

4

Centripetal retinal capillary proliferation in idiopathic parafoveolar telangiectasis.

Koizumi H, Cooney MJ, Leys A, Spaide RF. Koizumi H, et al. Br J Ophthalmol. 2007 Dec;91(12):1719-20. doi: 10.1136/bjo.2007.115485. Br J Ophthalmol. 2007. PMID: 18024824 Free PMC article. No abstract available.

5

Evolution of ophthalmic and electrophysiological findings in identical twin sisters with the carbohydrate deficient glycoprotein syndrome type 1 over a period of 14 years.

Casteels I, Spileers W, Leys A, Lagae L, Jaeken J. Casteels I, et al. Br J Ophthalmol. 1996 Oct;80(10):900-2. doi: 10.1136/bjo.80.10.900. Br J Ophthalmol. 1996. PMID: 8976701 Free PMC article.

6

Quality of life in patients with age-related macular degeneration: results from the VISION study.

Leys A, Zlateva G, Shah SN, Patel M. Leys A, et al. Eye (Lond). 2008 Jun;22(6):792-8. doi: 10.1038/sj.eye.6702900. Epub 2007 Jun 22. Eye (Lond). 2008. PMID: 17585313 Clinical Trial.

7

Retinal pigment epithelial detachments and tears, and progressive retinal degeneration in light chain deposition disease.

Spielberg LH, Heckenlively JR, Leys AM. Spielberg LH, et al. Among authors: leys am. Br J Ophthalmol. 2013 May;97(5):627-31. doi: 10.1136/bjophthalmol-2012-302851. Epub 2013 Feb 5. Br J Ophthalmol. 2013. PMID: 23385633 Free PMC article.

8

Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks.

Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F. Battaglia Parodi M, et al. Am J Ophthalmol. 2014 Feb;157(2):374-377.e2. doi: 10.1016/j.ajo.2013.10.015. Epub 2013 Nov 6. Am J Ophthalmol. 2014. PMID: 24211865

9

Intravitreal bevacizumab for myopic choroidal neovascularization: 1-year and 2-year results.

Coppens G, Angulo Bocco MI, Spielberg L, Leys A. Coppens G, et al. Bull Soc Belge Ophtalmol. 2010;(315):39-45. Bull Soc Belge Ophtalmol. 2010. PMID: 21110509

10

Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II).

Leys A, Vanrenterghem Y, Van Damme B, Snyers B, Pirson Y, Leys M. Leys A, et al. Eur J Ophthalmol. 1991 Jan-Mar;1(1):17-22. doi: 10.1177/112067219100100104. Eur J Ophthalmol. 1991. PMID: 1821193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters